Time to broaden the eligibility criteria in paediatric oncology trials? An analysis of patients with rhabdomyosarcoma non-eligible to the EpSSG RMS2005 trial
Purpose: Clinical trials include a series of eligibility and exclusion criteria that define the study population to reduce inter-patient heterogeneity and increase safety. Little is known about children with oncological diseases excluded from trials because they do not satisfy these criteria. We ana...
Main Authors: | Gianni Bisogno, Gian Luca De Salvo, Veronique Minard-Colin, Raquel Davila Fajardo, Beatrice Coppadoro, Meriel Jenney, Andrea Ferrari, Raquel Hladun Alvaro, Patrizia Dall’Igna, Heidi Glosli, Johannes H.M. Merks |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-01-01
|
Series: | EJC Paediatric Oncology |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2772610X23000120 |
Similar Items
-
Barriers to non-small cell lung cancer trial eligibility
by: Jeffrey J. Hardesty, et al.
Published: (2018-03-01) -
Local staging and treatment in extremity rhabdomyosarcoma. A report from the EpSSG‐RMS2005 study
by: Sheila E. J. Terwisscha van Scheltinga, et al.
Published: (2020-10-01) -
Drafting eligible biotech and immunotherapy claims
by: Shyh-Jen Wang
Published: (2019-11-01) -
Medical eligibility criteria for using various methods of contraception
by: V N Prilepskaya, et al.
Published: (2014-02-01) -
Investigating potential disparities in clinical trial eligibility and enrollment at an NCI‐designated comprehensive cancer center
by: Monica A. Patel, et al.
Published: (2023-06-01)